End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.84 CNY | +0.96% | +5.32% | +7.98% |
Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.98% | 3.22B | |
+24.41% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.21% | 233B | |
+5.51% | 201B | |
-10.27% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Fosun Pharma, Huahai, Three Other Chinese Firms to Produce Ingredients For Pfizer’s COVID-19 Drug